Sustainable care for children with cancer: a Lancet Oncology CommissionRifat Atun, Carlos Rodríguez‐Galindo, Nickhill Bhakta et al.|The Lancet Oncology|2020Cited by 346
Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3)V Di Carlo, S T Gershman, Jacques Estève et al.|JNCI Cancer Spectrum|2020Cited by 163
Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trialsValentina Guarneri, Fabio Girardi, Gaia Griguolo et al.|ESMO Open|2022Cited by 59
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trialValentina Guarneri, PierFranco Conte, Maria Vittoria Dieci et al.|European Journal of Cancer|2021Cited by 42
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast CancerFederica Miglietta, Maria Vittoria Dieci, Daniela Iannaccone et al.|Clinical Cancer Research|2023Cited by 13